The New Orleans BioFund was created to support small businesses in the region looking to grow, create jobs, and contribute to the economic revitalization of New Orleans. Capital is often difficult to obtain for small businesses and startups, which are high-risk ventures. The innovative BioFund program supports small businesses that may not qualify for traditional financing options. These investments help bridge a critical funding gap, thus allowing companies to better position themselves for growth and success.
The New Orleans BioFund operates in all industries, but places a special emphasis on biotechnology as a part of its mission. Furthermore, the fund is currently transitioning to a micro-venture capital model. This will provide startup investment options such as equity, convertible debt, and loan financing options.
The BioFund was kick started with funding from the U.S. Department of Housing and Urban Development and the Office of Community Development Disaster Recovery Unit to provide capital to startup companies looking to achieve growth, thereby increasing their potential for contribution to the economic development of Louisiana.
Company Details
- Founded
- -
- Address
- 1441 Canal St, New Orleans,louisiana 70112,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- HQ
- New Orleans, Louisiana
New Orleans Biofund Questions
New Orleans Biofund's website is http://www.neworleansbio.com/programs/biofund/
New Orleans Biofund's LinkedIn profile is https://www.linkedin.com/company/new-orleans-biofund
New Orleans Biofund's industry is
Venture Capital and Private Equity Principals
New Orleans Biofund's top competitors are
Herald,
South Rampart Pharma, Inc.,
Obatala Sciences,
Analysis Group,
William Blair,
Tonix Pharmaceuticals,
Maine Venture Fund,
New Orleans Bioinnovation Center,
Biodistrict New Orleans,
Mirimus.
New Orleans Biofund's categories are Venture Capital and Private Equity Principals
New Orleans Biofund's founding year is 2012
